John Kelly
Patrimonio netto: 45 418 $ in data 31/07/2026
Patrimonio netto: 45 418 $ in data 31/07/2026
John Kelly is the founder of Atomo Diagnostics Ltd., founded in 2010, where the title held was Chief Executive Officer, Director & MD from 2025 to 2026.
Mr. Kelly is currently a Non-Executive Director at Tetratherix Ltd. Formerly, Mr. Kelly was Chief Operating Officer at Unilife Corp.
Education includes undergraduate studies at The University of Liverpool, an MBA from The University of Sydney, and graduate studies at Queen's University Belfast A.F.C.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
TETRATHERIX LIMITED 0,02% | 30/06/2025 | 8.680 ( 0,02% ) | 45 418 $ | 31/07/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| TETRATHERIX LIMITED | Direttore/Membro del Consiglio | - |
| Società | Posizione | Fine |
|---|---|---|
| ATOMO DIAGNOSTICS LIMITED | Amministratore Delegato | 19/08/2026 |
| UNILIFE CORPORATION | Direttore operativo | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 6 |
|---|---|
Unilife Corp.
Unilife Corp. Medical SpecialtiesHealth Technology Designs, develops, manufactures and markets syringes & other medical devices | Health Technology |
The University of Liverpool
The University of Liverpool Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Sydney
The University of Sydney Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Atomo Diagnostics Ltd.
Atomo Diagnostics Ltd. Medical SpecialtiesHealth Technology Manufactures and markets blood testing vitro diagnostic medical devices | Health Technology |
Queen's University Belfast A.F.C.
Queen's University Belfast A.F.C. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tetratherix Pty Ltd.
Tetratherix Pty Ltd. Medical SpecialtiesHealth Technology Develops bio stealth fluid matrix and technology platform | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale